Soleno Therapeutics (SLNO) EPS (Basic) Growth (3y) (2016 - 2026)
Soleno Therapeutics (SLNO) EPS (Basic) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 64.84% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.21% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.99% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -38.31% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 36.73% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 67.51% |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | 38.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.76% |
| Dec 31, 2025 | 28.35% |
| Sep 30, 2025 | -26.34% |
| Jun 30, 2025 | -56.96% |
| Mar 31, 2025 | 6.68% |
| Dec 31, 2024 | -34.96% |
| Sep 30, 2024 | -38.35% |
| Jun 30, 2024 | -2.67% |
| Mar 31, 2024 | -17.05% |
| Dec 31, 2023 | 61.01% |
| Sep 30, 2023 | -44.97% |
| Jun 30, 2023 | 40.49% |
| Mar 31, 2023 | 35.94% |
| Dec 31, 2021 | -82.42% |
| Sep 30, 2021 | -73.73% |
| Jun 30, 2021 | -91.80% |
| Mar 31, 2021 | -63.43% |
| Dec 31, 2020 | -28.90% |
| Sep 30, 2020 | -79.26% |
| Jun 30, 2020 | -44.06% |